Arch Clinical Trials

St Louis, Missouri 63141

11 studies enrolling now · 22 studies all time

What they study most

Alzheimer Disease, Bipolar 1 Disorder, Bipolar Disorder, Bipolar Disorder Type I With Mania, Bipolar Disorder Type I With Mania or Mania With Mixed Features, Bipolar I Disorder, Cognitive Impairment Associated With Schizophrenia (CIAS), Depressive Disorder, Major, Major Depressive Disorder, Mania, Opioid Use Disorder, Schizophrenia

Studies at this site

• A Study of Brenipatide in Adult Participants With Schizophrenia — Recruiting now
• A Study of Brenipatide in Adult Participants With Major Depressive Disorder — Recruiting now
• A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse — Recruiting now
• 52-week Open Label Safety-Tolerability Study — Recruiting now
• Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. — Recruiting now
• Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia — Recruiting now
• A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2) — Recruiting now
• A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine — Recruiting now
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder — Recruiting now
• Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) — Completed
• Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression — Completed
• Multiple Ascending Dose Phase 1 Study of ALA-3000 — Completed
• BHV-7000 Acute Treatment of Bipolar Mania — Completed
• Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder — Completed
• BHV-7000 Open-Label Extension Bipolar Mania Study — Stopped early
• An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) — Completed
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months — Stopped early
• An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4) — Completed
• A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) — Completed